320 related articles for article (PubMed ID: 17430181)
1. Casein phosphopeptides in oral health--chemistry and clinical applications.
Cross KJ; Huq NL; Reynolds EC
Curr Pharm Des; 2007; 13(8):793-800. PubMed ID: 17430181
[TBL] [Abstract][Full Text] [Related]
2. Anticariogenic complexes of amorphous calcium phosphate stabilized by casein phosphopeptides: a review.
Reynolds EC
Spec Care Dentist; 1998; 18(1):8-16. PubMed ID: 9791302
[TBL] [Abstract][Full Text] [Related]
3. Anticariogenicity of calcium phosphate complexes of tryptic casein phosphopeptides in the rat.
Reynolds EC; Cain CJ; Webber FL; Black CL; Riley PF; Johnson IH; Perich JW
J Dent Res; 1995 Jun; 74(6):1272-9. PubMed ID: 7629336
[TBL] [Abstract][Full Text] [Related]
4. Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions.
Reynolds EC
J Dent Res; 1997 Sep; 76(9):1587-95. PubMed ID: 9294493
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of remineralization potential of casein phosphopeptide-amorphous calcium phosphate and casein phosphopeptide-amorphous calcium phosphate fluoride on artificial enamel white spot lesion: an in vitro light fluorescence study.
Mehta R; Nandlal B; Prashanth S
Indian J Dent Res; 2013; 24(6):681-9. PubMed ID: 24552927
[TBL] [Abstract][Full Text] [Related]
6. Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature.
Llena C; Forner L; Baca P
J Contemp Dent Pract; 2009 May; 10(3):1-9. PubMed ID: 19430620
[TBL] [Abstract][Full Text] [Related]
7. NMR studies of a novel calcium, phosphate and fluoride delivery vehicle-alpha(S1)-casein(59-79) by stabilized amorphous calcium fluoride phosphate nanocomplexes.
Cross KJ; Huq NL; Stanton DP; Sum M; Reynolds EC
Biomaterials; 2004 Sep; 25(20):5061-9. PubMed ID: 15109869
[TBL] [Abstract][Full Text] [Related]
8. Combined Casein Phosphopeptide-Amorphous Calcium Phosphate and Fluoride Is Not Superior to Fluoride Alone in Early Carious Lesions: A Meta-Analysis.
Golzio Navarro Cavalcante B; Schulze Wenning A; Szabó B; László Márk C; Hegyi P; Borbély J; Németh O; Bartha K; Gerber G; Varga G
Caries Res; 2024; 58(1):1-16. PubMed ID: 37883928
[TBL] [Abstract][Full Text] [Related]
9. [Casein phosphopeptide--amorphous calcium phosphate (CPP-ACP) and its effect on dental hard tissues].
Neuhaus KW; Lussi A
Schweiz Monatsschr Zahnmed; 2009; 119(2):110-6. PubMed ID: 19306597
[TBL] [Abstract][Full Text] [Related]
10. Review of casein phosphopeptides-amorphous calcium phosphate.
Reema SD; Lahiri PK; Roy SS
Chin J Dent Res; 2014; 17(1):7-14. PubMed ID: 25028684
[TBL] [Abstract][Full Text] [Related]
11. The potential ecological effects of casein phosphopeptide-amorphous calcium phosphate in dental caries prevention.
Philip N; Walsh L
Aust Dent J; 2019 Mar; 64(1):66-71. PubMed ID: 30375646
[TBL] [Abstract][Full Text] [Related]
12. Effects of an anticariogenic casein phosphopeptide on calcium diffusion in streptococcal model dental plaques.
Rose RK
Arch Oral Biol; 2000 Jul; 45(7):569-75. PubMed ID: 10785520
[TBL] [Abstract][Full Text] [Related]
13. An
Thakkar PJ; Badakar CM; Hugar SM; Hallikerimath S; Patel PM; Shah P
J Indian Soc Pedod Prev Dent; 2017; 35(4):312-318. PubMed ID: 28914243
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of nano bioactive glass for improving enamel remineralization ability of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP).
Akbarzade T; Farmany A; Farhadian M; Khamverdi Z; Dastgir R
BMC Oral Health; 2022 Nov; 22(1):525. PubMed ID: 36424610
[TBL] [Abstract][Full Text] [Related]
15. Calcium phosphopeptides -- mechanisms of action and evidence for clinical efficacy.
Cochrane NJ; Reynolds EC
Adv Dent Res; 2012 Sep; 24(2):41-7. PubMed ID: 22899678
[TBL] [Abstract][Full Text] [Related]
16. Effect of slow-release fluoride devices and casein phosphopeptide/amorphous calcium phosphate nanocomplexes on enamel remineralization in vitro.
Al-Mullahi AM; Toumba KJ
Caries Res; 2010; 44(4):364-71. PubMed ID: 20668378
[TBL] [Abstract][Full Text] [Related]
17. A Review of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) and Enamel Remineralization.
Gupta N; Mohan Marya C; Nagpal R; Singh Oberoi S; Dhingra C
Compend Contin Educ Dent; 2016 Jan; 37(1):36-9; quiz 40. PubMed ID: 26863219
[TBL] [Abstract][Full Text] [Related]
18. Enamel subsurface lesion remineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride.
Cochrane NJ; Saranathan S; Cai F; Cross KJ; Reynolds EC
Caries Res; 2008; 42(2):88-97. PubMed ID: 18204252
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of fluorescence changes after application of casein phosphopeptides (CPP) and amorphous calcium phosphate (ACP) on early carious lesions.
Altenburger MJ; Gmeiner B; Hellwig E; Wrbas KT; Schirrmeister JF
Am J Dent; 2010 Aug; 23(4):188-92. PubMed ID: 21250566
[TBL] [Abstract][Full Text] [Related]
20. Long-term remineralizing effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) on early caries lesions in vivo: a systematic review.
Li J; Xie X; Wang Y; Yin W; Antoun JS; Farella M; Mei L
J Dent; 2014 Jul; 42(7):769-77. PubMed ID: 24705069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
